Specific HIV-1 reverse transcriptase inhibitors

about

Mode of inhibition of HIV reverse transcriptase by 2-hexaprenylhydroquinone, a novel general inhibitor of RNA-and DNA-directed DNA polymerases

P2860

Q28379011-53A2CE9E-4958-4F0D-B61C-E05F79A3667E

P2860

Specific HIV-1 reverse transcriptase inhibitors

Item

http://www.wikidata.org/entity/Q28342783

description

1992 nî lūn-bûn

@nan

1992 թուականին հրատարակուած գիտական յօդուած

@hyw

1992 թվականին հրատարակված գիտական հոդված

@hy

1992年の論文

@ja

1992年論文

@yue

1992年論文

@zh-hant

1992年論文

@zh-hk

1992年論文

@zh-mo

1992年論文

@zh-tw

1992年论文

@wuu

name

Specific HIV-1 reverse transcriptase inhibitors

@ast

Specific HIV-1 reverse transcriptase inhibitors

@en

Specific HIV-1 reverse transcriptase inhibitors

@nl

type

Item

label

Specific HIV-1 reverse transcriptase inhibitors

@ast

Specific HIV-1 reverse transcriptase inhibitors

@en

Specific HIV-1 reverse transcriptase inhibitors

@nl

prefLabel

Specific HIV-1 reverse transcriptase inhibitors

@ast

Specific HIV-1 reverse transcriptase inhibitors

@en

Specific HIV-1 reverse transcriptase inhibitors

@nl

P1476

Specific HIV-1 reverse transcriptase inhibitors

@en

P2093

K Andries

http://www.w3.org/2001/XMLSchema#string

R Pauwels

http://www.w3.org/2001/XMLSchema#string

Z Debyser

http://www.w3.org/2001/XMLSchema#string

P2860

Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives

Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor

An antiviral target on reverse transcriptase of human immunodeficiency virus type 1 revealed by tetrahydroimidazo-[4,5,1-jk] [1,4]benzodiazepin-2 (1H)-one and -thione derivatives

A novel dipyridodiazepinone inhibitor of HIV-1 reverse transcriptase acts through a nonsubstrate binding site

Potent and selective inhibition of human immunodeficiency virus type 1 (HIV-1) by 5-ethyl-6-phenylthiouracil derivatives through their interaction with the HIV-1 reverse transcriptase

Genome organization and transactivation of the human immunodeficiency virus type 2.

Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV.

New acquisitions in the development of anti-HIV agents.

Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative.

P304

47-53

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/14756369209041355

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Erik De Clercq

P577

1992-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

1285302

http://www.w3.org/2001/XMLSchema#string

Specific HIV-1 reverse transcriptase inhibitors

about

P2860

P2860

Specific HIV-1 reverse transcriptase inhibitors

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698